By Susan Ning Hazel Yin and Ruohan Zhang King&Wood Mallesons’ Antitrust Group
On May 4, 2015, the National Development and Reform Commission (NDRC) published the Notice on Reinforcing Supervision over Drug Prices (“Notice”). The Notice includes a range of specific issues on the supervision over drug price, including immediately launching special inspections into illegal conducts